China · Delayed Price · Currency is CNY Theseus Pharmaceuticals Statistics
Total Valuation
SHA:603119 has a market cap or net worth of CNY 23.62 billion. The enterprise value is 22.81 billion.
| Market Cap | 23.62B |
| Enterprise Value | 22.81B |
Important Dates
The next estimated earnings date is Saturday, August 30, 2025.
| Earnings Date | Aug 30, 2025 |
| Ex-Dividend Date | Jun 17, 2025 |
Share Statistics
SHA:603119 has 362.81 million shares outstanding. The number of shares has increased by 6.15% in one year.
| Current Share Class | 362.81M |
| Shares Outstanding | 362.81M |
| Shares Change (YoY) | +6.15% |
| Shares Change (QoQ) | -0.99% |
| Owned by Insiders (%) | 47.45% |
| Owned by Institutions (%) | 12.00% |
| Float | 189.41M |
Valuation Ratios
The trailing PE ratio is 98.71 and the forward PE ratio is 74.39.
| PE Ratio | 98.71 |
| Forward PE | 74.39 |
| PS Ratio | 19.92 |
| PB Ratio | 12.51 |
| P/TBV Ratio | 12.95 |
| P/FCF Ratio | 155.18 |
| P/OCF Ratio | 95.94 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 80.28, with an EV/FCF ratio of 149.88.
| EV / Earnings | 93.89 |
| EV / Sales | 19.24 |
| EV / EBITDA | 80.28 |
| EV / EBIT | 95.71 |
| EV / FCF | 149.88 |
Financial Position
The company has a current ratio of 4.68, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.68 |
| Quick Ratio | 3.59 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | 0.16 |
| Interest Coverage | 175.54 |
Financial Efficiency
Return on equity (ROE) is 13.55% and return on invested capital (ROIC) is 8.16%.
| Return on Equity (ROE) | 13.55% |
| Return on Assets (ROA) | 7.06% |
| Return on Invested Capital (ROIC) | 8.16% |
| Return on Capital Employed (ROCE) | 12.30% |
| Revenue Per Employee | 761,477 |
| Profits Per Employee | 156,026 |
| Employee Count | 1,557 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 3.47 |
Taxes
In the past 12 months, SHA:603119 has paid 31.95 million in taxes.
| Income Tax | 31.95M |
| Effective Tax Rate | 11.62% |
Stock Price Statistics
The stock price has increased by +307.19% in the last 52 weeks. The beta is 0.27, so SHA:603119's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | +307.19% |
| 50-Day Moving Average | 46.53 |
| 200-Day Moving Average | 34.04 |
| Relative Strength Index (RSI) | 77.02 |
| Average Volume (20 Days) | 18,371,895 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603119 had revenue of CNY 1.19 billion and earned 242.93 million in profits. Earnings per share was 0.66.
| Revenue | 1.19B |
| Gross Profit | 383.76M |
| Operating Income | 238.31M |
| Pretax Income | 274.89M |
| Net Income | 242.93M |
| EBITDA | 281.22M |
| EBIT | 238.31M |
| Earnings Per Share (EPS) | 0.66 |
Balance Sheet
The company has 829.42 million in cash and 24.07 million in debt, giving a net cash position of 805.36 million or 2.22 per share.
| Cash & Cash Equivalents | 829.42M |
| Total Debt | 24.07M |
| Net Cash | 805.36M |
| Net Cash Per Share | 2.22 |
| Equity (Book Value) | 1.89B |
| Book Value Per Share | 5.08 |
| Working Capital | 1.14B |
Cash Flow
In the last 12 months, operating cash flow was 246.15 million and capital expenditures -93.97 million, giving a free cash flow of 152.18 million.
| Operating Cash Flow | 246.15M |
| Capital Expenditures | -93.97M |
| Free Cash Flow | 152.18M |
| FCF Per Share | 0.42 |
Margins
Gross margin is 32.37%, with operating and profit margins of 20.10% and 20.49%.
| Gross Margin | 32.37% |
| Operating Margin | 20.10% |
| Pretax Margin | 23.19% |
| Profit Margin | 20.49% |
| EBITDA Margin | 23.72% |
| EBIT Margin | 20.10% |
| FCF Margin | 12.84% |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.31%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 0.31% |
| Dividend Growth (YoY) | 9.27% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 16.20% |
| Buyback Yield | -6.15% |
| Shareholder Yield | -5.82% |
| Earnings Yield | 1.03% |
| FCF Yield | 0.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 18, 2024. It was a forward split with a ratio of 1.3.
| Last Split Date | Jun 18, 2024 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
SHA:603119 has an Altman Z-Score of 14.72 and a Piotroski F-Score of 4.
| Altman Z-Score | 14.72 |
| Piotroski F-Score | 4 |